Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

Biogen Inc.

Filed: Mar 11, 2026CIK: 0000875045
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Biogen's Chief Legal Officer Susan H. Alexander is departing effective end of May 2026, with the company initiating a search for her successor. This leadership transition could impact legal oversight and governance during a period of ongoing business operations and compliance efforts.

Key Takeaways

Susan H. Alexander, Chief Legal Officer, will depart Biogen effective May 31, 2026

The company has begun an active search for a successor to fill the Chief Legal Officer position

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 11, 2026
Item5.02
CategoryExecutive Change
CIK0000875045
Accession #2026-03-11
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
executive departureleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings